- December 6, 2017 | BY
Modulating the microbiome to treat disease, and employing sophisticated tools to ensure that CRISPR edits the right target. Hot topics to look for in 2018.
- December 4, 2017 | BY
What’s percolating in the field of Parkinson’s disease research? Scientists from Charles River and the Michael J. Fox Foundation discuss therapeutic advances, animal models and reproducibility
- December 1, 2017 | BY
Researchers search for clues to the origin of MS, details on how the first artificial DNA cells made a new protein, and is malaria on the rise?
- November 30, 2017 | BY
Our quest to obtain global accreditation inadvertently turns up a glitch in the scientific literature—a bacterium’s fraternal twin. MicroPhyles Case No. 6
- November 28, 2017 | BY
As we move toward correcting diseases in adult-affected tissue, we need better controls and a better understanding of what exactly is being done to our genomes
- November 22, 2017 | BY
The FDA’s actions address the promise of innovative products and mounting concerns over stem cell clinics
- November 21, 2017 | BY
From synthetic biology to super humanized mice, researchers offer glimpses of where cancer research is heading. A report from a Charles River symposium
- November 17, 2017 | BY
Scientists’ first-ever attempt at gene editing inside the body, does your body recover better during the day, and have we found a way to reverse diabetes?
- November 15, 2017 | BY
SfN 2017: How microdialysis and bioanalysis can aid in CNS drug discovery. A conversation with Brains On-Line scientist Gunnar Flik
- November 14, 2017 | BY
What computer models can teach us about how the mouse brain creates behavior. Our ongoing coverage of SfN 2017